title: Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?
authors.forename: L
authors.initials: L
authors.lastname: Colonna
authors.forename: G
authors.initials: G
authors.lastname: Cianchini
authors.forename: A
authors.initials: A
authors.lastname: Frezzolini
authors.forename: O
authors.initials: O
authors.lastname: De Pità
authors.forename: G
authors.initials: G
authors.lastname: Di Lella
authors.forename: P
authors.initials: P
authors.lastname: Puddu
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000628:therapy*
chemical_list: D016756:Immunoglobulins, Intravenous